Yuhan Corporation Overview
Pro stress-test →Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally, and also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical.
Strategic Profile
Pro stress-test →Yuhan is positioned as a smaller, innovative biopharma company with a single transformative asset, which contrasts sharply with global competitors like Pfizer, Merck, and AstraZeneca, which possess vast, diversified portfolios and multi-billion dollar R&D engines. High valuation and weak profits contrast with a strong balance sheet and high-potential drug, Leclaza.
Competitive Landscape
Pro stress-test →Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Globally, it competes against companies like Pfizer, Merck, and AstraZeneca, which possess vast, diversified portfolios and multi-billion dollar R&D engines.
Industry Context
Yuhan Corporation operates in Pharmaceuticals & Biotechnology.
Key facts
Founded: 1926 · Headquarters: Seoul, South Korea · Employees: 2066 · Revenue: $1.52B · Market cap: $5.46B